Drug Profile
Research programme: small molecule therapeutics - University of Texas M. D. Anderson Cancer Center/X-Chem
Latest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator University of Texas M. D. Anderson Cancer Center; X-Chem
- Class Antineoplastics; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer